Senior insider sale
EVP, Head of R&D at DIANTHUS THERAPEUTICS, INC. /DE/ — senior position signals high conviction
$2.90M
33.83K shares
What this filing means
RANDHAWA SIMRAT plans to sell 33.83K shares of DIANTHUS THERAPEUTICS, INC. /DE/ valued at approximately $2.90M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/12/2026ACC: 0001950047-26-002549
Officer· EVP, Head of R&D
Since Mar 2026
33.83K
Shares to sell
$2.90M
Approx. market value
33.83K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
3/12/2026
33.83KTotal acquired33.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/12/2026 | Exercise of Stock Options Cash | 33.83K | — |
| Total | 33.83K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
33.83K
Market value
$2.90M
3/12/2026
Total
Units
33.83K
Value
$2.90M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/12/2026 | 33.83K | $2.90M | NASDAQ | Planned |
| Total | 33.83K | $2.90M | ||